نتایج جستجو برای: mbc

تعداد نتایج: 3656  

Journal: :Breast 2009
Fatima Cardoso

Metastatic breast cancer (MBC) patients have long been treated as ‘‘forgotten heroes’’: forgotten by the research community, by the media, and even by the advocacy world and their fellow breast cancer patients with early disease. Everyone prefers a story with a happy ending, and the fatality burden associated with MBC is often too hard to deal with. It touches the profound human fears of suffer...

Journal: :Antimicrobial agents and chemotherapy 1987
R C Johnson C Kodner M Russell

The antimicrobial susceptibility of Borrelia burgdorferi isolated from human spinal fluid was determined in vitro and in vivo. A broth dilution technique was used to determine the MBCs of four antimicrobial agents. The Lyme disease spirochete was most susceptible to ceftriaxone (MBC, 0.04 microgram/ml) and erythromycin (MBC, 0.05 microgram/ml), then tetracycline (MBC, 0.8 microgram/ml), and fin...

Journal: :Clinical journal of oncology nursing 2013
Diana Donovan

Although considerable treatment advances have been made since the early 2000s, metastatic breast cancer (MBC) continues to provide challenges for patients and healthcare providers. The responsibilities of nurses regarding the management of MBC are extensive. Among other things, nurses must provide patient education, understand treatment administration, and have the ability to perform patient as...

2016
Peggy L. Lin Yanni Hao Jipan Xie Nanxin Li Yichen Zhong Zhou Zhou James E. Signorovitch Eric Q. Wu

Sequential endocrine therapy (ET) is recommended for postmenopausal women with hormone receptor-positive (HR+)/human epidermal growth factor receptor 2-negative (HER2-) metastatic breast cancer (mBC) and without visceral symptoms. Chemotherapy (CT) can be considered after sequential ETs, but is associated with adverse side effects. We assessed physicians' preferences and self-reported prescribi...

2014
Daniel Herrera Olga L. Rojas Carolina Duarte-Rey Rubén D. Mantilla Juana Ángel Manuel A. Franco

The mechanisms that contribute to the maintenance of serological memory are still unclear. Rotavirus (RV) memory B cells (mBc) are enriched in IgM(+) and CD27- subpopulations, which are associated with autoimmune diseases pathogenesis. In patients with autoimmune diseases treated with Rituximab (RTX), some autoantibodies (auto-Abs) decrease after treatment, but other auto-Abs and pathogen-speci...

2013
Su Yon Jung Margaret Rosenzweig

BACKGROUND Counseling and anticipatory guidance of the expected course of treatment for women newly diagnosed with metastatic breast cancer (MBC) are difficult due to multiple factors influencing survival following MBC therapy. In order to better tailor counseling at the onset and through the duration of MBC we used non-clinical trial data to better characterize real life experience of sequenti...

2011
Eva Muñoz-Couselo José Pérez-García Javier Cortés

Metastatic breast cancer (MBC) remains an incurable disease, with the goals of care aimed at maximizing the patient's duration and quality of life. Treatment options for MBC have become more efficacious and numerous. In addition to endocrine and chemotherapy agents, a number of targeted agents, including trastuzumab and bevacizumab, have further enhanced the landscape of therapeutic options. Er...

2011
Stephen Dyar Alvaro Moreno-Aspitia

There is an ongoing need for development of new chemotherapeutic regimens for metastatic breast cancer [mBC], especially when tumors lack therapeutic targets such as the estrogen or progesterone receptor [ER/PR], or the human epidermal growth factor receptor-2 [HER2]. Capecitabine is an orally bioavailable fluoropyrimidine approved for monotherapy in mBC, and bevacizumab is a monoclonal antibod...

2016
Celine Lefebvre Thomas Bachelot Thomas Filleron Marion Pedrero Mario Campone Jean-Charles Soria Christophe Massard Christelle Lévy Monica Arnedos Magali Lacroix-Triki Julie Garrabey Yannick Boursin Marc Deloger Yu Fu Frédéric Commo Véronique Scott Ludovic Lacroix Maria Vittoria Dieci Maud Kamal Véronique Diéras Anthony Gonçalves Jean-Marc Ferrerro Gilles Romieu Laurence Vanlemmens Marie-Ange Mouret Reynier Jean-Christophe Théry Fanny Le Du Séverine Guiu Florence Dalenc Gilles Clapisson Hervé Bonnefoi Marta Jimenez Christophe Le Tourneau Fabrice André

BACKGROUND Major advances have been achieved in the characterization of early breast cancer (eBC) genomic profiles. Metastatic breast cancer (mBC) is associated with poor outcomes, yet limited information is available on the genomic profile of this disease. This study aims to decipher mutational profiles of mBC using next-generation sequencing. METHODS AND FINDINGS Whole-exome sequencing was ...

Journal: :The oncologist 2012
Joyce A O'Shaughnessy Manfred Kaufmann Friederike Siedentopf Philippe Dalivoust Marc Debled Nicholas J Robert Nadia Harbeck

The goals of treatment for metastatic breast cancer (MBC) are to prolong overall survival (OS) while maximizing quality of life, palliating symptoms, and delaying tumor progression. For many years, anthracyclines and taxanes have been the mainstay of treatment for MBC, but these agents are now commonly administered earlier in the course of the disease. A recent meta-analysis revealed adverse ef...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید